BOSTON, Oct. 3, 2023 /PRNewswire/ -- CereVasc, Inc., a clinical-stage, medical device company developing novel treatments for neurological diseases, announced a milestone thirtieth patient received ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results